1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Thromboembolism in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YD; Guo, YT; Liu, HB; Tao, T; Wang, H; Wang, HJ; Wang, YT; Zhao, XN | 1 |
Butler, KD; Herd, CM; May, GR; Page, CP | 1 |
Dejana, E; Fuster, V; Lapetina, E; Moncada, S; Mustard, JF; Tans, G; Vargaftig, BB; Verstraete, M | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Thromboembolism
Article | Year |
---|---|
An overview of antiplatelet and antithrombotic drugs.
Topics: Adenosine Diphosphate; Arachidonic Acids; Arteriosclerosis; Blood Platelets; Blood Vessels; Endothelium; Epoprostenol; Erythrocyte Aggregation; Fibrinolytic Agents; Hemostasis; Humans; Phospholipases A; Phospholipids; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandins; Receptors, Prostaglandin; Receptors, Thromboxane; Thrombin; Thromboembolism; Thromboxane-A Synthase; Type C Phospholipases | 1985 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Thromboembolism
Article | Year |
---|---|
Prognostic factors of clinical endpoints in elderly patients with atrial fibrillation during a 2-year follow-up in China: An observational cohort study.
Topics: Age Factors; Aged; Aged, 80 and over; Atrial Fibrillation; Body Mass Index; C-Reactive Protein; Case-Control Studies; China; Digoxin; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Male; Platelet Activating Factor; Prognosis; Proportional Hazards Models; Prospective Studies; Thromboembolism | 2017 |
Radioisotopic model for investigating thromboembolism in the rabbit.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Collagen; Erythrocytes; Female; Indium Radioisotopes; Male; Models, Biological; Organometallic Compounds; Oxyquinoline; Platelet Activating Factor; Rabbits; Radionuclide Imaging; Thrombin; Thromboembolism | 1990 |